# Hypersensitivity Reaction to Vitrase (Ovine Hyaluronidase)

> **NCT00198419** · PHASE1 · COMPLETED · sponsor: **Bausch & Lomb Incorporated** · enrollment: 65 (actual)

## Conditions studied

- Drug Hypersensitivity

## Interventions

- **DRUG:** Vitrase

## Key facts

- **NCT ID:** NCT00198419
- **Lead sponsor:** Bausch & Lomb Incorporated
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-03
- **Primary completion:** 2004-03
- **Final completion:** 2004-03
- **Target enrollment:** 65 (ACTUAL)
- **Last updated:** 2013-03-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00198419

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00198419, "Hypersensitivity Reaction to Vitrase (Ovine Hyaluronidase)". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00198419. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*